SCN9A and medullary thyroid gland carcinoma: Overall, our data showed that NaV1.7 is uniquely overexpressed in MTC and suggested that NaV1.7 could serve as a target to develop small-molecule drugs and/or as a biomarker for diagnostic purposes.